The Legal Intelligencer | News
By Amanda O'Brien | February 16, 2024
Duke Fitch started at the company as a medicinal chemist and rose to vice president of U.S. pharmaceutical patents after earning his law degree.
By ALM Staff | December 11, 2023
This suit was surfaced by Law.com Radar. Read the complaint here.
By ALM Staff | July 27, 2023
This suit was surfaced by Law.com Radar. Read the complaint here.
The Legal Intelligencer | News
By Amanda O'Brien | June 26, 2023
Montgomery McCracken's former chief diversity and inclusion officer Alfred Zaher leads the group. Its mix of hourly billing and alternative fee arrangements will provide a new line of revenue for Berger Montague.
The Legal Intelligencer | Commentary
By Gerald B. Halt Jr. | June 26, 2023
The court explained that "if a patent claims an entire class of processes, machines, manufactures, or compositions of matter, the patent's specification must enable a person skilled in the art to make and use the entire class." "In other words, the specification must enable the full scope of the invention. The more one claims, the more one must enable."
By Charles Toutant | May 24, 2023
The judge rejected Mylan's claim that the 693 patent was invalid based on obviousness, meaning that a person of ordinary skill in the art could have formulated the patent's claims using publicly available information.
The Legal Intelligencer | Event
By Amanda O'Brien | March 29, 2023
Attorneys shouldn't fear having their actions thrown back at a corporation if it becomes a defendant. "Your job as a lawyer is to distinguish things," Brian Savage argued at a forum hosted by Dechert.
The Legal Intelligencer | Commentary
By Robert S. Silver | February 22, 2023
Litigation costs can be carefully controlled if one keeps their eye on the ball and is proactive with outside counsel and expenses.
By Scott Graham | November 2, 2022
Judge Mitchell Goldberg will let a patent infringement suit against Moderna over COVID-19 vaccine technology proceed in district court. But he left open the possibility that Arbutus Biopharma and Genevant Sciences could ultimately be sent to the Court of Federal Claims.
By ALM Staff | October 11, 2022
This suit was surfaced by Law.com Radar. Read the complaint here.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS